Your browser doesn't support javascript.
loading
Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
Sun, Liangbo; Jiang, Yangzhou; Yan, Xiaojing; Dai, Xufang; Huang, Chen; Chen, Lingxi; Li, Tao; Zhang, Yueting; Xiao, Hanxi; Yang, Mingzhen; Xiang, Li; Zhang, Yang; Chen, Sha; Li, Shuhui; Chen, An; He, Fengtian; Lian, Jiqin.
Affiliation
  • Sun L; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Jiang Y; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China; Battalion One of Basic Medical Sciences, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Yan X; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Dai X; Department of Educational College, Chongqing Normal University, Chongqing, 400038, China.
  • Huang C; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Chen L; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Li T; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Zhang Y; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Xiao H; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Yang M; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Xiang L; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Zhang Y; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Chen S; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Li S; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • Chen A; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
  • He F; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China. Electronic address: hefengtian66@aliyun.com.
  • Lian J; Department of Clinical Biochemistry, Army Medical University (Third Military Medical University), Chongqing, 400038, China; Department of Biochemistry and Molecular Biology, Army Medical University (Third Military Medical University), Chongqing, 400038, China. Electronic address: lianjiqin@tmmu.edu.
Exp Cell Res ; 406(1): 112755, 2021 09 01.
Article de En | MEDLINE | ID: mdl-34332981
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Résistance aux médicaments antinéoplasiques / MAP Kinase Kinase 4 / Acide dichloro-acétique / Protéine Mcl-1 / Sorafénib / Tumeurs du foie Type d'étude: Prognostic_studies Langue: En Journal: Exp Cell Res Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Résistance aux médicaments antinéoplasiques / MAP Kinase Kinase 4 / Acide dichloro-acétique / Protéine Mcl-1 / Sorafénib / Tumeurs du foie Type d'étude: Prognostic_studies Langue: En Journal: Exp Cell Res Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique